Serum sST2/ miR-223 as a Dual Biomarker for Disease Activity & Clinical Efficacy of SLIT in HDM-Induced Allergic Rhinitis

NCT07436208 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

OTHER_GOV

Sponsor class

Conditions

HDM-Induced Allergic Rhinitis

Interventions

BIOLOGICAL: Sublingual Immunotherapy (SLIT) containing HDM extracts

Sponsor

Zagazig University